Home / Publication / Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters

Publication

Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters

Author(s): Brahim Achour, Zubida M. Al-Majdoub, Agnieszka Grybos-Gajniak, Kristi Lea, Peter Kilford, Mian Zhang, David Knight, Jill Barber, Jeoffrey Schageman, Amin Rostami-Hodjegan

Year: November 3, 2020

Recommended for you

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

Blog

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

On-Demand Webinar

Certara’s Simcyp Educational Webinar Series: Learn from A to Z of PBBM Part 2: What is the Drug Absorption Model?

Webinar

Essentials of Model-informed Drug Development in Oncology

Blog

Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters

Liquid Biopsy Enables Quantification of the Abundance and Interindividual Variability of Hepatic Enzymes and Transporters

Redefining Regulatory Strategy with MIDD: Insights from the Draft ICH M15 Guidance

Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance

Certara’s Simcyp Educational Webinar Series: Learn from A to Z of PBBM Part 2: What is the Drug Absorption Model?

Essentials of Model-informed Drug Development in Oncology

Newsletter sign up

Quick links

Solutions

Contact